MedPath

Antibiotic Exposure During Pregnancy Affects Infant Gut Microbiota

Recruiting
Conditions
Antibiotics Affecting Newborn Gut Microbiota
Registration Number
NCT06479941
Lead Sponsor
Peking University People's Hospital
Brief Summary

Based on a prospective birth cohort, the investigators will collect biological samples from participants including pregnant women and newborns, to measure the gut microbial diversity and metabolites of newborns. These results systematically evaluate the effects of antibiotic exposure on the structure and function of gut microbiota. The project can reveal the effects of antibiotic exposure on the growth and development of gut microbiota in early life.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
450
Inclusion Criteria
  1. Pregnant woman

    • aged 20-40 years old
    • natural conception
    • single pregnancy
    • gestational age ≥36 weeks
  2. Newborn

    • normal Apgar score
    • no serious congenital diseases
Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Infant gut microbiomePregnancy (12, 24, 37 weeks) and infants (born, 1 week, and 1, 3, 6, 12 months)

* Diversity of gut microbiota

* Abundance of antibiotic resistance genes in gut microbiota

* Metabolic pathway of gut microbiota

Secondary Outcome Measures
NameTimeMethod
Antibiotic treatmentPregnancy (12, 24, 37 weeks) and infants (born, 1 week, and 1, 3, 6, 12 months)

* Frequency of antibiotic treatment

* Kind and Dose of antibiotic;

* Duration of antibiotic use;

Trial Locations

Locations (1)

The Peking University People's Hospital

🇨🇳

Beijing, China

The Peking University People's Hospital
🇨🇳Beijing, China
Xue Xu, Dr.
Contact
010-88324385
xuxue19877182@sina.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.